
Iovance Biotherapeutics, Inc.
USD5.48
+0.46 (+9.16%)
CEO
Frederick G. Vogt
IPO Date
2010-10-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.07
Prev. Close
$5.02
Day Low
$5.02
Day High
$5.53
52W Low
$1.76
52W High
$5.63
Market Cap
$1.96B
Volume
19.99M
| 3 Mar 2026 |
| Citizens |
| Market Perform |
| Market Outperform |
| upgrade |
| 25 Feb 2026 | Barclays | Overweight | Overweight | maintain |
| 25 Feb 2026 | Citizens | Market Perform | Market Outperform | upgrade |
| 17 Dec 2025 | Barclays | Overweight | Overweight | maintain |
| 24 Nov 2025 | Barclays | Overweight | Overweight | maintain |
| 6 Nov 2025 | Chardan Capital | Buy | Buy | maintain |
| 29 Oct 2025 | HC Wainwright & Co. | Buy | Buy | maintain |